Drug Shortage Report for ALVESCO

Last updated on 2017-10-02 History
Report ID 22634
Drug Identification Number 02285614
Brand name ALVESCO
Common or Proper name ciclesonide
Company Name ASTRAZENECA CANADA INC
Active Ingredient(s) CICLESONIDE
Strength(s) 200MCG
Dosage form(s) AEROSOL, METERED DOSE
Route of administration INHALATION
Packaging size 120 doses
ATC code R03BA
ATC description OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2017-10-06
Actual start date
Estimated end date 2017-10-20
Actual end date 2017-10-02
Shortage status Avoided shortage
Updated date 2017-10-02
Company comments
Health Canada comments
Company contact information Please contact AstraZeneca Canada Medical Information for any specific questions at 1-800-668-6000 (EN) or 1-800-461-3787 (FR) or by email: medinfo.canada@astrazeneca.com.

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2017-10-02 French Compare
v4 2017-10-02 English Compare
v3 2017-09-19 French Compare
v2 2017-09-19 English Compare
v1 2017-09-19 English Compare